Conexeu Sciences Inc.

Conexeu Sciences Inc.

Private
Reno, NevadaHealthcare & Life Scienceshttps://conexeu.com/

Last Round

Seed Round

May 21, 2026

Est. Valuation

$30M

Total Funding Raised

$6.34M

Momentum Score

25 /100

Company Overview

Conexeu Sciences Inc. is a biotechnology company developing a patented bioregenerative extracellular matrix platform for applications in wound care, medical aesthetics, and tissue engineering.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Advanced Materials, 3D Printing

Business Model

B2B

Customer Profile

Hardware Sales, Data as a Service, Government Contracts

AI Layer

Non-AI

Keywords

regenerative tissuecollagen scaffoldwound caremedical aestheticsthermosensitive hydrogeltissue engineeringhuman collagenbiomaterialsdermal fillerextracellular matrix3D bioprintingtissue regenerationbioinkinjectable scaffoldscar reductionreconstructive surgery510(k) clearancedental soft tissue repair

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Conexeu Sciences Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Conexeu Sciences Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Seed RoundMay 21, 2026
Seed RoundMay 21, 2026
Seed RoundFeb 27, 2026
CrowdfundingOct 16, 2025
SeedMay 8, 2025
Seed
Oct 1, 2023

Key People

Founding team and executive leadership

Jeff Sharpe

Chief Executive Officer, Director

Executive Team

Miles Harrison

President Chief Executive Officer

Executive Team

Conexeu Sciences Inc. Investors

Notable investors and investment history

InvestorRounds
EquifundCrowdfunding
The University of British ColumbiaSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2026

    $45K Seed Round raised

  • May 21, 2026

    $543M Seed Round completed.

Conexeu Sciences Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Conexeu Sciences Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Conexeu Sciences Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersReno, Nevada
Employee Range10
Year Founded2022
Last FundingMay 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.